XML 62 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock Option And Stock Award Plans (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Summary Of Stock Options Outstanding summary of stock options outstanding at December 31, 2021, 2020 and 2019, and changes during those years, is presented below:
  Option Exercise Price/Share
  Number of
Options
RangeWeighted
Average
Outstanding at January 1, 2019890,116 $15.65 to$24.84 $19.69 
Granted758,287 18.48 to18.48 18.48 
Forfeited and expired(10,000)19.40 to19.40 19.40 
Exercised(9,500)19.40 to19.40 19.40 
Outstanding at December 31, 20191,628,903 15.65 to24.84 19.13 
Granted638,074 10.75 to14.62 11.90 
Modification for special cash dividend(a)
701,535 10.75 to14.62 11.90 
Forfeited and expired(a)
(141,074)10.75 to24.84 11.87 
Outstanding at December 31, 2020(a)
2,827,438 10.75 to22.49 13.55 
Granted388,822 16.37 to16.37 16.37 
Forfeited and expired(22,611)14.47 to19.64 18.14 
Exercised(67,705)10.75 to17.29 13.51 
Outstanding at December 31, 20213,125,944 $10.75 to$22.49 $13.82 
(a) The option exercise price per share reflects the reduction to the exercise prices of outstanding stock options impacted by the modification due to the anti-dilution provisions in the stock-based compensation plan.
Summary Of Additional Information On Stock Options Outstanding And Exercisable
The following table summarizes additional information about stock options outstanding and exercisable at December 31, 2021:
 Options Outstanding at December 31, 2021Options Exercisable at December 31, 2021
  Weighted AverageAggregate Intrinsic Value  Aggregate Intrinsic Value
Range of
Exercise Prices
SharesRemaining Contractual LifeExercise
Price
SharesWeighted Average Exercise Price
$10.75 to$16.37 2,953,052 4.4 years$13.48 $792,082 1,589,298 $13.78 $41,076 
17.29 to25.94 172,892 1.6 years19.71 — 172,892 19.71 — 
Total3,125,944 4.2 years$13.82 $792,082 1,762,190 $14.36 $41,076 
Summary Of Additional Information On Non-Vested Restricted Stock Outstanding The following table summarizes additional information about unvested restricted stock outstanding at December 31, 2021, 2020 and 2019:
 Unvested Restricted StockMaximum Unvested Restricted Stock Units Issuable Upon Satisfaction of Certain Performance Criteria
 Number
of Shares
Weighted Avg. Grant Date Fair Value/ShareGrant Date
Fair Value
(In thousands)
Number
of Shares
Weighted Avg. Grant Date Fair Value/ShareGrant Date
Fair Value
(In thousands)
Outstanding at January 1, 2019244,736 $16.20 $3,965 184,709 $16.97 $3,134 
Granted185,422 18.46 3,423 57,442 18.34 1,053 
Vested(117,834)14.76 (1,739)(69,926)10.96 (766)
Forfeited(26,389)16.11 (425)(24,562)11.51 (283)
Outstanding at December 31, 2019285,935 18.27 5,224 147,663 21.25 3,138 
Granted155,138 14.55 2,257 34,275 15.25 523 
Vested(148,709)17.39 (2,586)(37,370)17.38 (649)
Forfeited(57,385)17.00 (976)(32,066)17.36 (557)
Outstanding at December 31, 2020234,979 16.68 3,919 112,502 21.82 2,455 
Granted200,073 15.63 3,127 14,669 15.24 224 
Vested(87,636)15.78 (1,383)(73,930)17.17 (1,269)
Forfeited(11,616)16.38 (190)(2,523)17.63 (44)
Outstanding at December 31, 2021335,800 $16.30 $5,473 50,718 $17.63 $1,366 
Share-based Payment Arrangement, Stock Appreciation Right, Activity
  Exercise Price/Share
  Number of
SARs
RangeWeighted
Average
Outstanding at January 1, 2020— $— to$— $— 
Granted(a)
387,252 10.75 to19.64 11.60 
Modification for special cash dividend71,402 10.75 to19.64 11.60 
Forfeited and expired(82,214)10.75 to19.64 11.39 
Outstanding at December 31, 2020376,440 10.75 to19.64 11.64 
Granted164,464 16.37 to16.37 16.37 
Forfeited and expired(10,043)10.75 to16.37 13.01 
Exercised(9,260)10.75 to15.25 13.87 
Outstanding at December 31, 2021521,601 $10.75 to$16.37 $13.55 
(a) The SARs exercise price per share reflects the reduction to the exercise prices of outstanding SARs as a results of the modification to the awards pursuant to the nondiscretionary anti-dilution provisions in the related SARs grant agreements.